Results 151 to 160 of about 167,631 (303)

Targets of Elf5 in Mouse Trophoblast Stem Cells

open access: yes, 2007
The Placenta is an essential organ for all mammalian embryonic development as it provides the nutritional link between maternal and foetal blood streams.
Deane, Jessica Robyn
core  

Evaluating predictive values of umbilical cord arterial lactate for adverse newborn outcomes among term‐births in northern Uganda: A cross sectional analytical study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 408-420, April 2025.
Abstract Objective Birth asphyxia is one of the leading causes of death for neonates worldwide. Lack of an objective cost effective test to predict poor newborn outcomes at birth affects the ability to respond appropriately. This study determined predictive values of umbilical cord arterial lactate in relation to adverse neonatal outcomes. Methods This
Elizabeth Ayebare   +7 more
wiley   +1 more source

Optimal timing for induction of labor in normotensive women: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 365-371, April 2025.
Abstract Objective Labor induction is offered to reduce the risk of stillbirth at late term (41+0 to 41+6) but earlier induction in normotensive singleton pregnancies is supported by weak evidence. The aim of the present study was to investigate the optimal timing for induction in normotensive women.
Jóhanna Gunnarsdóttir   +3 more
wiley   +1 more source

Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 206-214, April 2025.
Abstract Objective Antiphospholipid antibodies (aPL) are recognized to have a pivotal role in recurrent pregnancy loss (RPL) and cardiovascular disease. Therefore, we assessed the vascular function of women with RPL and examined the association with each type of aPL.
Titi Yang   +11 more
wiley   +1 more source

NuViva: Development of postpartum nutrition and exercise program implementing the FIGO pregnancy passport to reduce cardiometabolic risk

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Pregnancy provides a unique opportunity to identify women at increased risk of future chronic disease, as adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, gestational diabetes mellitus, preterm birth, placental complications, and fetal growth restriction are associated with later cardiometabolic morbidity. However,
Nikki M. W. Lee   +4 more
wiley   +1 more source

Functional status of women with and without potentially life‐threatening maternal conditions after 6 months postpartum: A cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective The aim of this study was to evaluate the impact of potentially life‐threatening maternal conditions (PLTCs) on functional disability at 6 months postpartum. Methods This prospective cohort study was done at 10 hospitals in Tigray, northern Ethiopia. A total of 1027 postpartum women (341 with PLTCs and 686 without) were enrolled into
Fitiwi Tinsae Baykemagn   +3 more
wiley   +1 more source

Corioangioma gigante de la placenta complicado con hematoma retroplacentario. Presentación de una paciente

open access: yes, 2016
The abnormal proliferation of vessels derived from the placenta is known as chorioangioma, although it is the most common placental benign tumor not trophoblastic of the placenta occurs in a frequency as low as 1% of pregnancies.
Bravo Torres, Yarima   +2 more
core  

Postpartum anemia and maternal wellbeing: A cohort analysis of the WOMAN‐2 trial

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective We examined the association between postpartum anemia and maternal wellbeing in women who gave birth with anemia. Methods We conducted a cohort analysis using secondary data from the WOMAN‐2 trial. Between August 2019 and September 2023, women with moderate or severe anemia who were giving birth vaginally were recruited from ...
The WOMAN‐2 Trial Collaborators   +180 more
wiley   +1 more source

Home - About - Disclaimer - Privacy